Page last updated: 2024-11-04

gatifloxacin and Innate Inflammatory Response

gatifloxacin has been researched along with Innate Inflammatory Response in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Research Excerpts

ExcerptRelevanceReference
" The mean peak concentration in plasma of 4."1.30A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose. ( Andrews, JM; Ashby, JP; Marshall, J; Wise, R, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wise, R1
Andrews, JM1
Ashby, JP1
Marshall, J1

Other Studies

1 other study available for gatifloxacin and Innate Inflammatory Response

ArticleYear
A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5

    Topics: Administration, Oral; Adult; Anti-Infective Agents; Cantharidin; Exudates and Transudates; Fluoroqui

1999